查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1934191

無標定檢測市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、技術、應用、地區和競爭格局分類，2021-2031年）

Label-Free Detection, Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球無標定偵測 (LFD) 市場預計將從 2025 年的 19.1 億美元成長到 2031 年的 29.1 億美元，複合年成長率為 7.21%。

無標定檢測 (LFD) 是一種生物分析技術，它不依賴螢光或放射性標記物，能夠即時觀察分子相互作用，從而保持分析物的天然狀態。這一市場趨勢的主要驅動力是製藥業日益成長的需求，即提高藥物研發效率並減少後期研發失敗率。根據歐洲製藥工業協會聯合會 (EFPIA) 預測，到 2024 年，歐洲以研發為基礎的製藥業預計將在研發方面投入約 550 億歐元。這項數據表明，巨大的經濟利益正在推動製藥業採用 LFD 等高精度分析工具，以最佳化研究成果並最大化投資回報。

市場概覽
預測期 2027-2031
市場規模：2025年 19.1億美元
市場規模：2031年 29.1億美元
複合年成長率：2026-2031年 7.21%
成長最快的細分市場 表面等離子體共振（SPR）
最大的市場 北美洲

儘管有這些促進因素，但由於LFD設備需要高昂的初始資本投入，市場仍面臨許多障礙，這往往限制了小規模學術實驗室和新興生物技術公司使用該設備。數據分析固有的技術複雜性進一步加劇了這種成本敏感性，因為並非所有研究環境都具備專門的培訓。因此，這些財務和營運方面的障礙對這項技術在全球生命科學界的廣泛應用構成了重大挑戰。

市場促進因素

醫藥品研究開發費用的醫藥品研究開發費用成長是推動無標定檢測技術應用的主要因素。面對簡化藥物研發流程和降低後期失敗率的壓力，製藥公司正積極投資能夠提供高精度動力學數據的生物分析工具。主要產業參與者優先考慮縮短先導化合物發現時間並提高結合親和性測量準確性的技術，這充分體現了上述投資。例如，根據《先導化合物技術》雜誌報道，默克公司在2024年5月公佈，其2023年全年研發支出將達到305億美元，這反映了整個行業投資於藥物發現基礎設施的趨勢，而這些基礎設施依賴用於精確分子相互作用分析的專用設備。

同時，對生物製劑和個人化醫療日益成長的關注正在重塑對無標定系統的需求。與小分子不同，諸如單株抗體等複雜生物製劑在用螢光標記物標記後，其結合行為通常會發生改變，因此，在篩檢中，無標定分析對於保持分析物的天然結構至關重要。這些大分子療法的商業性成功正在推動市場需求。普渡大學報告稱，截至2024年5月，美國FDA已核准2023年上市的24種生物製藥，佔新上市療法的絕大多數。此外，旨在保障研究能力的公共部門措施正在加強全球生態系統。據英國政府稱，已於2024年10月設立了5.2億英鎊的生命科學創新製造基金，旨在促進該領域的投資，並創造有利於先進分析技術廣泛應用的環境。

市場挑戰

無標定偵測 (LFD) 儀器的高昂初始資本投入是其市場擴張的一大障礙。這些先進的分析系統需要大量的前期投資，這往往阻礙了預算有限的小規模學術實驗室和新興生物技術公司採用。與大型製藥企業不同，這些小規模的機構難以承擔這些成本，只能依賴傳統的、成本較低的標記方法。這種價格敏感性實際上排除了很大一部分潛在客戶，限制了該技術在生命科學領域的普及，使其主要集中在資金雄厚的機構中。

生物技術領域資金籌措環境的惡化進一步加劇了這一財務障礙。據生物技術創新組織（BIO）稱，「2024年第一季，早期藥物研發公司的創業投資投資額預計約為24億美元，反映出新興企業資金籌措環境較為謹慎。」 由於資金籌措有限，新興企業被迫優先考慮臨床開發支出，而非購買昂貴的資本設備。因此，這些新興企業購買力的下降直接抑制了對LFD設備的需求，阻礙了整個市場的成長。

市場趨勢

人工智慧 (AI) 和機器學習在動力學分析中的應用，從根本上改變了無標定檢測領域中複雜結合數據的解讀方式。隨著生物分析平台產生的資料集日益龐大，人工處理已成為瓶頸，促使人們採用能夠即時分解複雜動力學曲線的運算工具。這項數位化轉型源自於提高結合親和性計算精度以及在藥物研發早期預測分子行為的需求。產業對此技術變革的投入也反映在近期的資本配置中。根據皮斯托亞聯盟 (Pistoia Alliance) 2025 年 9 月發布的《未來實驗室調查》，人工智慧仍是 63% 生命科學實驗室的重點投資領域，這支持了向數據驅動型分析框架的策略轉型，從而提升無標定儀器的效用。

同時，自動化和機器人整合工作流程的興起，滿足了藥物篩檢領域對高通量和高重複性的需求，從而推動了市場成長。實驗室越來越重視能夠支持大規模宣傳活動連續無人運作的系統，摒棄了容易出現偏差的手動樣品處理方式。製造商也積極回應，推出了可無縫整合到機器人生態系統中並最大限度提高設備利用率的先進儀器。例如，賽多利斯公司宣布將於2025年5月推出其Octet R8e系統，並指出該平台採用的新型蒸發控制技術可實現長達16小時的無人實驗運作。這項特性顯著延長了動力學分析的運行時間，從而滿足了現代高通量環境所需的連續分析需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

5. 全球無標定偵測 (LFD) 市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（耗材、設備）
    • 透過技術（質譜法、表面等離子體共振法（SPR）、生物層干涉法、等溫滴定量熱法、差示掃描量熱法等）
    • 依應用領域（結合動力學、結合動態、內源性受體檢測、先導化合物確認、先導化合物生成等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美無標定偵測 (LFD) 市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲無標定偵測 (LFD) 市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區無標定檢測（LFD）市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲無標定檢測 (LFD) 市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲無標定檢測 (LFD) 市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球無標定偵測（LFD）市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Ametek Inc
  • Corning Incorporated
  • Cytiva（Danaher Corporation）
  • Horiba Ltd.
  • Malvern Panalytical Ltd
  • PerkinElmer Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23385

The Global Label-Free Detection (LFD) Market is projected to expand from USD 1.91 Billion in 2025 to USD 2.91 Billion by 2031, reflecting a CAGR of 7.21%. Label-free detection (LFD) refers to bioanalytical methods that facilitate the real-time observation of molecular interactions without relying on fluorescent or radioactive markers, thereby maintaining the analyte's natural state. This market trajectory is primarily supported by the pharmaceutical sector's intensifying need to enhance drug discovery efficiency and reduce late-stage development failures. According to 'EFPIA', in '2024', 'the research-based pharmaceutical industry invested an estimated €55,000 million in R&D in Europe', a statistic that underscores the massive financial stakes driving the adoption of high-fidelity analytical tools like LFD to optimize research outcomes and maximize return on investment.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.91 Billion
Market Size 2031USD 2.91 Billion
CAGR 2026-20317.21%
Fastest Growing SegmentSurface Plasmon Resonance (SPR)
Largest MarketNorth America

Despite these drivers, the market faces a significant impediment regarding the high initial capital expenditure required for LFD instrumentation, which often restricts access for smaller academic laboratories and emerging biotechnology firms. This cost sensitivity is compounded by the technical complexity inherent in data analysis, necessitating specialized training that may not be available in all research settings. Consequently, these financial and operational barriers present a substantial challenge to the broader penetration of this technology across the global life sciences community.

Market Driver

Escalating Pharmaceutical R&D Expenditure for Drug Discovery and Development serves as a paramount catalyst for the adoption of label-free detection technologies. As pharmaceutical entities face pressure to streamline drug development pipelines and mitigate late-stage attrition, they are aggressively channeling capital into bioanalytical tools that offer high-fidelity kinetic data. This financial commitment is evident in the strategies of major industry players who prioritize technologies capable of accelerating hit-to-lead times and improving the accuracy of binding affinity measurements. For instance, according to Pharmaceutical Technology, in May 2024, Merck & Co. reported a research and development expenditure of $30.5 billion for the full year 2023, reflecting a broader industry trend toward capitalizing discovery infrastructures that rely on specialized instrumentation for precise molecular interaction analysis.

Concurrently, the Increasing Focus on Biologics and Personalized Medicine is reshaping the demand for label-free systems. Unlike small molecules, complex biologics such as monoclonal antibodies often exhibit altered binding behaviors when tagged with fluorescent markers, making label-free analysis indispensable for preserving native analyte conformation during screening. The rising commercial success of these large-molecule therapeutics fuels this demand; according to Purdue University, in May 2024, the US FDA approved 24 biologics in 2023, representing a substantial share of novel therapeutics entering the market. Furthermore, the global ecosystem is strengthened by public sector initiatives aimed at securing research capabilities. According to the UK Government, in October 2024, a £520 million Life Sciences Innovative Manufacturing Fund was launched to catalyze investment in the sector, fostering an environment conducive to the proliferation of advanced analytical technologies.

Market Challenge

The high initial capital expenditure required for label-free detection (LFD) instrumentation constitutes a substantial barrier to market expansion. These advanced analytical systems necessitate a significant upfront investment, which often renders them inaccessible to smaller academic laboratories and emerging biotechnology firms that operate with limited discretionary budgets. Unlike major pharmaceutical corporations, these smaller entities struggle to absorb such costs, forcing them to rely on traditional, less expensive labeling methods. This price sensitivity effectively excludes a large segment of the potential customer base, thereby limiting the technology's penetration into the broader life sciences community and concentrating usage primarily within well-funded institutions.

This financial impediment is further intensified by the tightening funding environment for the biotechnology sector. According to the 'Biotechnology Innovation Organization', in '2024', 'venture capital investment in early-stage therapeutic companies tracked at approximately $2.4 billion in the first quarter, reflecting a cautious funding environment for emerging enterprises'. When capital availability is restricted, startups are compelled to prioritize clinical development expenses over the acquisition of premium capital equipment. Consequently, the reduced purchasing power of these emerging firms directly suppresses the demand for LFD instrumentation, hampering the overall growth trajectory of the market.

Market Trends

The Integration of Artificial Intelligence and Machine Learning for Kinetic Analysis is fundamentally reshaping the interpretation of complex binding data in the label-free detection sector. As bioanalytical platforms generate increasingly voluminous datasets, manual processing has become a bottleneck, prompting the adoption of computational tools capable of deconvoluting intricate kinetic profiles in real-time. This digital transformation is driven by the necessity to improve the accuracy of binding affinity calculations and predict molecular behaviors earlier in the discovery pipeline. The industry's commitment to this technological shift is evident in recent capital allocations; according to the Pistoia Alliance, September 2025, in the 'Lab of the Future survey', artificial intelligence remained the primary investment priority for 63% of life science laboratories, underscoring a strategic pivot toward data-driven analytical frameworks that enhance the utility of label-free instrumentation.

Concurrently, the Shift Toward Automated and Robotic-Integrated Workflows is accelerating market growth by addressing the demand for higher throughput and reproducibility in drug screening. Laboratories are increasingly moving away from manual sample handling, which is prone to variability, favoring systems that support continuous, walk-away operation for large-scale campaigns. Manufacturers are responding with advanced instrumentation designed to integrate seamlessly into robotic ecosystems, thereby maximizing instrument utilization rates. For instance, according to Sartorius, May 2025, in the 'Octet R8e System' launch announcement, the platform's new evaporation control technology now enables unattended experimental run times of up to 16 hours, a capability that significantly extends operational windows for kinetic assays and facilitates the uninterrupted analysis required by modern high-throughput environments.

Key Market Players

  • Ametek Inc
  • Corning Incorporated
  • Cytiva (Danaher Corporation)
  • Horiba Ltd.
  • Malvern Panalytical Ltd
  • PerkinElmer Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific

Report Scope

In this report, the Global Label-Free Detection (LFD) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Label-Free Detection (LFD) Market, By Product

  • Consumables
  • Instruments

Label-Free Detection (LFD) Market, By Technology

  • Mass Spectrometry
  • Surface Plasmon Resonance (SPR)
  • Bio-Layer Interferometry
  • Isothermal Titration Calorimetry
  • Differential Scanning Calorimetry
  • Other

Label-Free Detection (LFD) Market, By Application

  • Binding Kinetics
  • Binding Thermodynamics
  • Endogenous Receptor Detection
  • Hit Confirmation
  • Lead Generation
  • Other

Label-Free Detection (LFD) Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Label-Free Detection (LFD) Market.

Available Customizations:

Global Label-Free Detection (LFD) Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Label-Free Detection (LFD) Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Instruments)
    • 5.2.2. By Technology (Mass Spectrometry, Surface Plasmon Resonance (SPR), Bio-Layer Interferometry, Isothermal Titration Calorimetry, Differential Scanning Calorimetry, Other)
    • 5.2.3. By Application (Binding Kinetics, Binding Thermodynamics, Endogenous Receptor Detection, Hit Confirmation, Lead Generation, Other)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Label-Free Detection (LFD) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Label-Free Detection (LFD) Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Label-Free Detection (LFD) Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Label-Free Detection (LFD) Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application

7. Europe Label-Free Detection (LFD) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Label-Free Detection (LFD) Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
    • 7.3.2. France Label-Free Detection (LFD) Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Label-Free Detection (LFD) Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Label-Free Detection (LFD) Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Label-Free Detection (LFD) Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application

8. Asia Pacific Label-Free Detection (LFD) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Label-Free Detection (LFD) Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
    • 8.3.2. India Label-Free Detection (LFD) Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Label-Free Detection (LFD) Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Label-Free Detection (LFD) Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Label-Free Detection (LFD) Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application

9. Middle East & Africa Label-Free Detection (LFD) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Label-Free Detection (LFD) Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Label-Free Detection (LFD) Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Label-Free Detection (LFD) Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application

10. South America Label-Free Detection (LFD) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Label-Free Detection (LFD) Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Label-Free Detection (LFD) Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Label-Free Detection (LFD) Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Label-Free Detection (LFD) Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ametek Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Corning Incorporated
  • 15.3. Cytiva (Danaher Corporation)
  • 15.4. Horiba Ltd.
  • 15.5. Malvern Panalytical Ltd
  • 15.6. PerkinElmer Inc.
  • 15.7. Shimadzu Corporation
  • 15.8. Thermo Fisher Scientific

16. Strategic Recommendations

17. About Us & Disclaimer